Skip to main content
PRE
NASDAQ Industrial Applications And Services

Prenetics' IM8 Secures Jay Shetty as Global Ambassador and Shareholder

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$15.54
Mkt Cap
$245.948M
52W Low
$5.58
52W High
$23.63
52W Position info
178% above low
Off High info
34% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

PRE has more than doubled off its 52-week low of $5.58.

Summary

Prenetics' IM8 brand announced a multi-year global partnership with wellness influencer Jay Shetty, who will also become a shareholder, expanding the brand's reach beyond sports.


Key Events · M&A and Partnerships · PRE

  • New Global Ambassador

    IM8, Prenetics' health and longevity brand, partnered with Jay Shetty, a #1 New York Times bestselling author and podcast host, as its first global ambassador from outside the world of sport.

  • Equity Alignment

    Jay Shetty also becomes a shareholder in Prenetics, aligning his long-term interests with the company, similar to other high-profile partners like David Beckham and Giannis Antetokounmpo.

  • Expands Brand Reach

    Shetty brings a massive global community of over 70 million followers in wellness and mindfulness, significantly broadening IM8's target audience beyond its existing sports-focused partnerships.

  • Reinforces Growth Strategy

    This partnership reinforces Prenetics' strategic focus on its IM8 brand, following recent strong Q1 results and raised full-year 2026 revenue guidance for IM8 to $190 million to $210 million.


Analysis · PRE · Industrial Applications And Services

This partnership significantly expands IM8's brand reach into the global wellness and mindfulness audience through Jay Shetty's massive following. His equity stake in Prenetics aligns his long-term interests with the company's success, reinforcing the strategy of securing high-profile, equity-aligned ambassadors. This move supports the company's recently raised revenue guidance for IM8 and strengthens its position in the consumer health market.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 35.7% of the 1694 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.10%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRE was trading at $15.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $245.9M. The 52-week trading range was $5.58 to $23.63. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRE - Latest Insights

PRE
Aug 26, 2026, 8:23 AM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $22.17
Real-time Price: $23.93 info
Change: +$1.76 (+8%) info
Market Cap: $402.357M info
PRE
Aug 24, 2026, 9:41 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $21.82
Real-time Price: $23.93 info
Change: +$2.11 (+10%) info
Market Cap: $402.357M info
PRE
Aug 20, 2026, 10:32 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $18.76
Real-time Price: $23.93 info
Change: +$5.18 (+28%) info
Market Cap: $402.357M info
PRE
Aug 18, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $19.99
Real-time Price: $23.93 info
Change: +$3.94 (+20%) info
Market Cap: $402.357M info
PRE
Aug 18, 2026, 7:33 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $19.45
Real-time Price: $23.93 info
Change: +$4.48 (+23%) info
Market Cap: $402.357M info